Gems Management »

iShares NASDAQ Biotechnology Index shares owned by Gems Management

Quarter-by-quarter ownership of iShares NASDAQ Biotechnology Index (IBB) shares owned by Gems Management from 13F filings

Historical chart of Gems Management investment in iShares NASDAQ Biotechnology Index

Tip: Access up to 7 years of quarterly data

All positions including iShares NASDAQ Biotechnology Index held by Gems Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares NASDAQ Biotechnology Index by Gems Management

Quarter filed Position value Share count Share price at filing
2013-09-30 $471k 2.2k 209.43
2013-06-30 $687k 3.9k 173.97
2013-03-31 $457k 2.9k 159.79

More positions owned by Gems Management

Powershares Etf Trust dyna buybk ach
WisdomTree Japan Total Dividend (DXJ)
iShares Russell 2000 Value Index (IWN)
Global X Fds glb x ftse nor (GURU)
WisdomTree Europe SmallCap Div (DFE)
Wisdomtree Tr intl hedge eqt (HEDJ)
Credit Suisse Nassau Brh invrs vix sterm
Baidu (BIDU)
Applied Materials (AMAT)
priceline.com Incorporated
Micron Technology (MU)
MasterCard Incorporated (MA)
Netflix (NFLX)
Yahoo!
salesforce (CRM)

View all positions for Gems Management

Top funds holding iShares NASDAQ Biotechnology Index

Bank of America Corporation
Bnp Paribas Arbitrage, Snc
Susquehanna International
Citigroup
Farallon Capital Management
Jane Street
PEAK6 Investments
Royal Bank of Canada
Goldman Sachs Group
Citadel Advisors
UBS Group
Wells Fargo & Company
Commerce Bank N A
Healthcare Of Ontario Pension Plan Trust Fund
LPL Financial

View all funds holding iShares NASDAQ Biotechnology Index